Panagopoulos P - Search Results

1

Testing Hepatitis E Seroprevalence among HIV-Infected Patients in Greece: The SHIP Study.

Antonopoulou N, Schinas G, Kotsiri Z, Tsachouridou O, Protopapas K, Petrakis V, Petrakis EC, Papageorgiou D, Tzimotoudis D, Metallidis S, Papadopoulos A, Marangos M, Barbounakis E, Kofteridis DP, Panagopoulos P, Gogos C, Vantarakis A, Akinosoglou K. Antonopoulou N, et al. Among authors: panagopoulos p. Pathogens. 2024 Jun 24;13(7):536. doi: 10.3390/pathogens13070536. Pathogens. 2024. PMID: 39057763 Free PMC article.

2

Efficacy and safety of an anti-retroviral combination regimen including either efavirenz or lopinavir-ritonavir with a backbone of two nucleoside reverse transcriptase inhibitors.

Panagopoulos P, Tsiodras S, Antoniadou A, Katsarolis I, Papadopoulos A, Poulakou G, Giamarellou H. Panagopoulos P, et al. Clin Microbiol Infect. 2006 May;12(5):486-9. doi: 10.1111/j.1469-0691.2006.01372.x. Clin Microbiol Infect. 2006. PMID: 16643529 Free article.

3

HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease.

Lekakis J, Tsiodras S, Ikonomidis I, Palios J, Poulakou G, Rallidis L, Antoniadou A, Panagopoulos P, Papadopoulos A, Giamarellou H, Kremastinos DT. Lekakis J, et al. Among authors: panagopoulos p. Clin Sci (Lond). 2008 Sep;115(6):189-96. doi: 10.1042/CS20070353. Clin Sci (Lond). 2008. PMID: 18251713

4

Successful virological outcome in an HIV-infected individual with a three-class resistant variant and an insertion in the protease genome with a Tipranavir based regimen.

Panagopoulos P, Paraskevis D, Antoniadou A, Papadopoulos A, Poulakou G, Hatzakis A, Giamarellou H. Panagopoulos P, et al. Ir J Med Sci. 2010 Jun;179(2):305-7. doi: 10.1007/s11845-008-0211-6. Epub 2008 Sep 10. Ir J Med Sci. 2010. PMID: 18781283

5

In vitro elution of moxifloxacin and fusidic acid by a synthetic crystallic semihydrate form of calcium sulphate (Stimulan).

Panagopoulos P, Tsaganos T, Plachouras D, Carrer DP, Papadopoulos A, Giamarellou H, Kanellakopoulou K. Panagopoulos P, et al. Int J Antimicrob Agents. 2008 Dec;32(6):485-7. doi: 10.1016/j.ijantimicag.2008.06.029. Epub 2008 Sep 13. Int J Antimicrob Agents. 2008. PMID: 18790611

6

Association of highly active antiretroviral therapy with increased arterial stiffness in patients infected with human immunodeficiency virus.

Lekakis J, Ikonomidis I, Palios J, Tsiodras S, Karatzis E, Poulakou G, Rallidis L, Antoniadou A, Panagopoulos P, Papadopoulos A, Triantafyllidi H, Giamarellou H, Kremastinos DT. Lekakis J, et al. Among authors: panagopoulos p. Am J Hypertens. 2009 Aug;22(8):828-34. doi: 10.1038/ajh.2009.90. Epub 2009 Jun 25. Am J Hypertens. 2009. PMID: 19556973

7

Association of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms with increased infection risk in patients with advanced HIV-1 infection.

Papadopoulos AI, Ferwerda B, Antoniadou A, Sakka V, Galani L, Kavatha D, Panagopoulos P, Poulakou G, Kanellakopoulou K, van der Meer JW, Giamarellos-Bourboulis EJ, Netea MG. Papadopoulos AI, et al. Among authors: panagopoulos p. Clin Infect Dis. 2010 Jul 15;51(2):242-7. doi: 10.1086/653607. Clin Infect Dis. 2010. PMID: 20521908

8

Microcirculatory vascular dysfunction in HIV-1 infected patients receiving highly active antiretroviral therapy.

Palios J, Ikonomidis I, Lekakis J, Tsiodras S, Poulakou G, Antoniadou A, Panagopoulos P, Papadopoulos A, Giamarellou H, Anastasiou-Nana M, Kremastinos D. Palios J, et al. Among authors: panagopoulos p. Microcirculation. 2010 May;17(4):303-10. doi: 10.1111/j.1549-8719.2010.00023.x. Microcirculation. 2010. PMID: 20536743

9

Effects of first antiretroviral regimen on lipid levels in HIV (+) individuals.

Papadopoulos A, Pantazis N, Panagopoulos P, Kourkounti S, Xylomenos G, Chini M, Petrikkos G, Sambatakou H, Ioannidou P, Kordosis T, Panos G, Touloumi G. Papadopoulos A, et al. Among authors: panagopoulos p. J Chemother. 2012 Feb;24(1):38-47. doi: 10.1179/1120009X12Z.0000000008. J Chemother. 2012. PMID: 22546723

10

Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection.

Papadopoulos AI, Ferwerda B, Antoniadou A, Sakka V, Galani L, Kavatha D, Panagopoulos P, Poulakou G, Protopapas K, van der Meer JW, Netea MG, Giamarellos-Bourboulis EJ. Papadopoulos AI, et al. Among authors: panagopoulos p. Cytokine. 2012 Oct;60(1):104-7. doi: 10.1016/j.cyto.2012.05.008. Epub 2012 Jun 8. Cytokine. 2012. PMID: 22683004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters